Medical University of South Carolina
This study investigates the safety and potential efficacy of personalized, image-guided low intensity focused ultrasound (LIFU) targeting the thalamus in individuals with Autism Spectrum Disorder (ASD). The study evaluates behavioral, neuroimaging, and electrophysiological outcomes following LIFU stimulation using a non-invasive device.
Inclusion Criteria: * Age 13-25 * Diagnosis of ASD (DSM-5) * Full Scale IQ \> 70 * Verbal communication * Stable medication for ≥1 month * Ability to consent or assent with guardian consent Exclusion Criteria: * MRI or LIFU contraindications * Recent investigational drug/device use * Neurological illness (e.g., epilepsy, TBI) * Substance use disorder * Sensory/motor impairments preventing task completion
In this open label study, all participants will receive active LIFU
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.